Forte Biosciences, Inc. · NASDAQ:FBRX
Janus Henderson Group PLC reported a 9.90% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 9.90% stake in Forte Biosciences, Inc., 657,509 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 657,509
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 9.90% | 657,509 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.90% | 657,509 |
Source
Related
- Forte Biosciences, Inc.
- Janus Henderson Group PLC
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 7, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026